Drug intelligence / Profile preview

CUF2

Development stage: Phase 2
Administration: Oral

Overview

CUF2 is an herbal formula derived from classical Chinese medicine, designed to treat childhood asthma. Pre-clinical studies have indicated that CUF2 possesses anti-inflammatory and immunomodulatory activities. The formula is being investigated for its ability to improve clinical symptoms, modulate biochemical markers, and potentially reduce the reliance on conventional steroid dosages in children suffering from mild to moderate asthma.

Other names: Herbal Formula CUF2

Beyond the preview

Go deeper on CUF2.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CUF2.

Explore the full profile